CSF ELISA Tests

Our CE-certified cerebro-spinal fluid (CSF) ELISA kits in combination with the hAβ42/hAβ40-Ratio provide a precise and simple way to analyze human Amyloid β1-40 and β1-42 peptides present in the CSF of patients suffering from Alzheimer’s disease. These tools are therefore ideal for early stage Alzheimer’s disease diagnosis or for clinical trials.

For further information regarding the assay procedure and working time, test contents, troubleshooting and related issues please download our user manuals or choose the product data sheets to find a summary of the key characteristcs of the products.

Cat.-No.	Description	Product Data Sheet	Product Manual
TK40	For quantification of Aβ40 peptides in cerebro-spinal fluid (CSF) samples using highly selective and specific monoclonal antibodies in a flexible 96 well format
TK42	For quantification of Aβ42 peptides in cerebro-spinal fluid (CSF) samples using highly selective and specific monoclonal antibodies in a flexible 96 well format
TK-Set	For quantification of Aβ40 and Aβ42 peptides in cerebro-spinal fluid (CSF) samples using highly selective and specific monoclonal antibodies in a flexible 96 well format	See above	See above

We are currently establishing several reference centers for our CSF ELISA tests throughout Europe. These reference centers act as central measurement point for their respective regions and patient CSF samples can be sent for measurement. Three reference centers have already opened in Bremen, Germany; Dresden, Germany and Ulm, Germany. Please contact us for details of our next European reference centers.

Please do not hesitate to contact us for all inquiries including prices, orders, availability and conditions. For price inquiries please use our Price Inquiry Contact Form.